Pharmaceutical Tablet Supply – Hormonal Contraceptives

The contract calls for the supply of bulk-packaged hormonal contraceptive tablets containing Levonorgestrel and Ethinyl Estradiol, adhering to stringent military and federal pharmaceutical standards to ensure safety, potency, and regulatory compliance. The product must meet all applicable quality control benchmarks required by the Department of Defense for distribution through its medical supply chain, with delivery directed to the place of performance in Hampton, Virginia, zip code 23665-2040. The procurement is classified as a subcontract under North American Industry Classification System code 325412, indicating manufacturing of pharmaceutical preparations. The solicitation was posted on July 14, 2026, with responses due by July 20, 2026, requiring timely submission from qualified vendors capable of fulfilling large-scale, bulk-order requirements under federal defense contracting protocols. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, which manages pharmaceutical logistics for military personnel and associated healthcare systems. All suppliers must demonstrate consistent ability to deliver compliant, reliably packaged pharmaceuticals to meet the operational readiness needs of federal medical services without disruption.